In The News,
In The News,
Chris joins ADVI with over 20 years of extensive experience in finance and accounting, having previously served as the CFO at The Purple Guys, An Ntiva Company, a rapidly expanding IT support and cybersecurity company. His expertise extends across the full M&A lifecycle, including both buy-side and sell-side transactions, making him instrumental in solidifying business value and preparing companies for expansion and exit. His tenure at ProPharma Group, the world’s largest research consulting organization, owned by the same group behind Mercalis, formerly TrialCard, further underscores his ability to elevate organizations to new revenue growth and profitability levels.
“Chris brings extensive M&A experience and a collaborative approach to problem-solving,” said Marc Samuels, CEO and President of ADVI. “His focus on scalable processes, accountability, and willingness to roll up his sleeves to get the job done makes him the perfect fit for our growing company.”
Chris’ primary focus at ADVI will be distilling complex financial modeling and analyses into actionable insights. He will work closely with solution leaders in advisory services and business development teams to maximize revenue, optimize sales, and collaborate with leadership on strategic planning and acquisitions.
“I am excited about the opportunity I see at ADVI. We are at a pivotal point in our growth trajectory, and I believe I can make a significant impact for everyone at ADVI and its stakeholders across the healthcare landscape,” said Chris.
Chris Wittwer’s appointment signifies ADVI’s commitment to its mission, vision, and values in its continued growth and success, ensuring the company is well-positioned to strive for excellence in serving its clients while accelerating its ability to make an impact.